The effect of tyramine, noradrenaline, and angiotensin on the blood pressure in hypertensive patients with aldosteronism and low plasma renin.
D000236:Adenoma / Q000503:physiopathology; D000310:Adrenal Gland Neoplasms / Q000503:physiopathology; D000328:Adult; D000804:Angiotensin II / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects*; D005260:Female; D006801:Humans; D006929:Hyperaldosteronism / Q000503:physiopathology*; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000627:therapeutic use*; D010673:Pheochromocytoma / Q000503:physiopathology; D012083:Renin / Q000378:metabolism*; D014439:Tyramine / Q000627:therapeutic use; D014655:Vascular Resistance / Q000187:drug effects
D000804:Angiotensin II; D012083:Renin; D009638:Norepinephrine; D014439:Tyramine